Livzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks

Bulletin Express

2025/11/05

Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.

The filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1196184338"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196184338\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196184338?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196184338","market":"hk","top_or_hot":-1,"title":"Livzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.</p>\n<p>The filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-11-05 19:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.</p>\n<p>The filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"麗珠醫藥","start_time":0,"source_url":"","article_id":"1196184338","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196184338","pubTimestamp":1762341834,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药集团股份有限公司(01513.HK/000513.SZ)发布翌日披露报表股本不变继续A股回购","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. reported no changes in the total number of issued H shares at 299,807,117 and no changes in the total number of issued A shares at 604,293,313 as of November 5, 2025. According to the announcement, both figures remained the same as on November 4, showing no new issuance or cancellation activity for that period.\nThe filing also detailed an ongoing A-share repurchase program on the Shenzhen Stock Exchange. Shares repurchased on various dates since December 2024 remain pending cancellation and have not yet been removed from the total share count. The most recent repurchase occurred on November 5, 2025, involving 164,200 A shares with a highest repurchase price of RMB 36.64, a lowest repurchase price of RMB 36.41, and an aggregate price of approximately RMB 5.999 million. All transactions have been carried out in compliance with relevant regulations, and the repurchased shares awaiting cancellation are disclosed in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}